NCT02564900 (Clinical Trials/ DS-8201a)

Study Title
Study of DS-8201a in Subjects With Advanced Solid Malignant Tumors (NCT02564900)

Trial Description
This is an open-label, two-part, multiple study to evaluate the safety and tolerability of DS-8201a in patients with advanced solid malignant tumors.

This trial is sponsored by Daiichi Sankyo Co., Ltd

Study Data

  • Condition: Advanced Solid Tumors
  • Interventions:
    • Drugs used in this trial
      • DS-8201a
  • Phase: I
  • Enrollment: 198
  • Start: August 2015
  • Estimated Completion: March 2018
  • Last verified:  April 2017
  • Last updated: April 2017

Study Schematic


Click here to Return to Drug map

Last Editorial review: August 30, 2017
Information based on (NIH/NCI) and other sources.